{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:28:30Z","timestamp":1760956110019,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773519"],"award-info":[{"award-number":["81773519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["YJSZHYX202018","ZHYX202026"],"award-info":[{"award-number":["YJSZHYX202018","ZHYX202026"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.intimp.2021.107888","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:36:23Z","timestamp":1624062983000},"page":"107888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genetic polymorphisms of chemokine (C-X-C motif) ligand 10 gene associated with hepatitis B virus infection in a Chinese Han population"],"prefix":"10.1016","volume":"98","author":[{"given":"Mengmeng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexue","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107888_b0005","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.107888_b0010","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.107888_b0015","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection\u2013natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107888_b0020","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine","volume":"322","author":"Beasley","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.107888_b0025","first-page":"33","article-title":"Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg","volume":"4","author":"Pongpipat","year":"1986","journal-title":"Asian Pacific J. Allergy Immunol."},{"key":"10.1016\/j.intimp.2021.107888_b0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state","volume":"151","author":"McMahon","year":"1985","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2021.107888_b0035","doi-asserted-by":"crossref","unstructured":"Polaris Observatory Collaborators, Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study, Lancet Gastroenterol. Hepatol. 3 (2018) 383\u2013403, doi: 10.1016\/S2468-1253(18)30056-6.","DOI":"10.1016\/S2468-1253(18)30056-6"},{"key":"10.1016\/j.intimp.2021.107888_b0040","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM199504203321604","article-title":"Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia","volume":"332","author":"Thursz","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107888_b0045","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1478-3231.2011.02507.x","article-title":"Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population","volume":"31","author":"Li","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2021.107888_b0050","article-title":"Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B","volume":"13","author":"Kim","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2021.107888_b0055","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/j.gastro.2007.12.044","article-title":"Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers","volume":"134","author":"Deng","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2021.107888_b0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4254\/wjh.v4.i3.105","article-title":"Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection","volume":"4","author":"Li","year":"2012","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.intimp.2021.107888_b0065","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ng.348","article-title":"A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians","volume":"41","author":"Kamatani","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2021.107888_b0070","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1016\/j.vaccine.2014.07.064","article-title":"Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine","volume":"32","author":"Duan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2021.107888_b0075","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking","volume":"168","author":"Dufour","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2021.107888_b0080","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1084\/jem.166.4.1084","article-title":"Biochemical characterization of a gamma interferon-inducible cytokine (IP-10)","volume":"166","author":"Luster","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2021.107888_b0085","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1128\/JVI.75.3.1332-1338.2001","article-title":"Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization","volume":"75","author":"Patzwahl","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2021.107888_b0090","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/hep.26263","article-title":"Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection","volume":"57","author":"Grebely","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2021.107888_b0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/jvh.12060","article-title":"Rapid downregulation of programmed death-1 and interferon-\u03b3-inducible protein-10 expression is associated with favourable outcome during antiviral treatment of chronic hepatitis B","volume":"20","author":"Hou","year":"2013","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.intimp.2021.107888_b0100","article-title":"Association of interferon-gamma induced protein 10 promoter polymorphisms with the disease progression of hepatitis B virus infection in Chinese Han population","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2021.107888_b0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3851\/IMP2992","article-title":"Association of interferon-gamma inducible protein 10 polymorphism with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B","volume":"21","author":"Limothai","year":"2016","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.intimp.2021.107888_b0110","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.30497","article-title":"A functional variant in ubiquitin conjugating enzyme E2 L3 contributes to hepatitis B virus infection and maintains covalently closed circular DNA stability by inducing degradation of apolipoprotein B mRNA editing enzyme catalytic subunit 3A","volume":"69","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2021.107888_b0115","unstructured":"Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association, [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)], Zhonghua Gan Zang Bing Za Zhi 27 (2019) 938\u2013961, doi: 10.3760\/cma.j.issn.1007-3418.2019.12.007."},{"key":"10.1016\/j.intimp.2021.107888_b0120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3851\/IMP1866","article-title":"Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside\/nucleotide analogues","volume":"16","author":"Jaroszewicz","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.intimp.2021.107888_b0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jhep.2013.08.023","article-title":"Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy","volume":"60","author":"Papatheodoridis","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2021.107888_b0130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.14348\/molcells.2017.0051","article-title":"IP-10 expression in patients with chronic HBV infection and its ability to predict the decrease in HBsAg levels after treatment with entecavir","volume":"40","author":"Zhao","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.intimp.2021.107888_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081329","article-title":"CXCL10 gene promoter polymorphism -1447A>G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria","volume":"8","author":"Wilson","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2021.107888_b0140","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1164\/rccm.2107139","article-title":"Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease","volume":"165","author":"Saetta","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2021.107888_b0145","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s13054-020-03328-0","article-title":"CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS","volume":"24","author":"Blot","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2021.107888_b0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2021.107888_b0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tube.2018.01.005","article-title":"CXCL10 is overexpressed in active tuberculosis patients compared to M. tuberculosis-exposed household contacts","volume":"109","author":"Bhattacharyya","year":"2018","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.intimp.2021.107888_b0160","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/gene.2015.40","article-title":"IL6 gene allele-specific C\/EBP\u03b1-binding activity affects the development of HBV infection through modulation of Th17\/Treg balance","volume":"16","author":"Zhang","year":"2015","journal-title":"Genes Immun."},{"key":"10.1016\/j.intimp.2021.107888_b0165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/humu.21209","article-title":"Quantifying the effect of sequence variation on regulatory interactions","volume":"31","author":"Manke","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.intimp.2021.107888_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002599","article-title":"Widespread site-dependent buffering of human regulatory polymorphism","volume":"8","author":"Maurano","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.intimp.2021.107888_b0175","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.194.12.1755","article-title":"Blocking chemokine responsive to gamma-2\/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes","volume":"194","author":"Kakimi","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2021.107888_b0180","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2021.107888_b0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2005.08.009","article-title":"Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives","volume":"25","author":"Chuang","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2021.107888_b0190","doi-asserted-by":"crossref","first-page":"37015","DOI":"10.1038\/srep37015","article-title":"Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:25:57Z","timestamp":1747308357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921005245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":38,"alternative-id":["S1567576921005245"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107888","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic polymorphisms of chemokine (C-X-C motif) ligand 10 gene associated with hepatitis B virus infection in a Chinese Han population","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107888"}}